1. Home
  2. WST vs GFL Comparison

WST vs GFL Comparison

Compare WST & GFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • GFL
  • Stock Information
  • Founded
  • WST 1923
  • GFL 2007
  • Country
  • WST United States
  • GFL Canada
  • Employees
  • WST N/A
  • GFL N/A
  • Industry
  • WST Medical/Dental Instruments
  • GFL
  • Sector
  • WST Health Care
  • GFL
  • Exchange
  • WST Nasdaq
  • GFL Nasdaq
  • Market Cap
  • WST 20.1B
  • GFL 17.5B
  • IPO Year
  • WST N/A
  • GFL 2020
  • Fundamental
  • Price
  • WST $275.12
  • GFL $43.54
  • Analyst Decision
  • WST Strong Buy
  • GFL Strong Buy
  • Analyst Count
  • WST 9
  • GFL 10
  • Target Price
  • WST $354.50
  • GFL $57.97
  • AVG Volume (30 Days)
  • WST 778.7K
  • GFL 1.4M
  • Earning Date
  • WST 10-23-2025
  • GFL 11-05-2025
  • Dividend Yield
  • WST 0.32%
  • GFL 0.14%
  • EPS Growth
  • WST 0.17
  • GFL N/A
  • EPS
  • WST 6.75
  • GFL 6.65
  • Revenue
  • WST $3,017,900,000.00
  • GFL $5,904,199,182.00
  • Revenue This Year
  • WST $6.97
  • GFL N/A
  • Revenue Next Year
  • WST $6.11
  • GFL $6.56
  • P/E Ratio
  • WST $40.80
  • GFL $6.55
  • Revenue Growth
  • WST 4.92
  • GFL 27.49
  • 52 Week Low
  • WST $187.43
  • GFL $41.29
  • 52 Week High
  • WST $348.90
  • GFL $52.00
  • Technical
  • Relative Strength Index (RSI)
  • WST 50.14
  • GFL 40.26
  • Support Level
  • WST $262.48
  • GFL $43.11
  • Resistance Level
  • WST $287.98
  • GFL $45.25
  • Average True Range (ATR)
  • WST 11.52
  • GFL 1.04
  • MACD
  • WST -2.08
  • GFL -0.05
  • Stochastic Oscillator
  • WST 22.00
  • GFL 32.22

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About GFL GFL Environmental Inc. Subordinate voting shares no par value

GFL Environmental Inc is an environmental services company. Its offerings include non-hazardous solid waste management, infrastructure, soil remediation, and liquid waste management services. Its solid waste management business line, which generates the majority of the revenue, consists of the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste. Its Environmental Services business line includes liquid waste and soil remediation. The company's geographical segments are Canada and the United States. The company derives the majority of its revenue from the United States.

Share on Social Networks: